From: A novel hybrid model to predict concomitant diseases for Hashimoto’s thyroiditis
Disease | Gene | Reference |
---|---|---|
Myasthenia gravis | PTPN22, CTLA4 | |
Vitiligo | TYR, TG, TSHR, AIS1, forkhead transcription factor D3 (FOXD3), PTPN22 1858T (rs2476601), FOXP3 mutations TG/SLA | Cojocaru et al. [32], Said Fernandez et al. [33], Czajkowski [34] |
Rheumatoid arthritis | PTPN22 (rs2476601), HLA-DR, B1-Arg74, CTLA4, PTPN22, FCRL3, IL2RA, BTG1, FCRL3 | |
Type 1 diabetes | HLA-DRB1-03:01, HLA-DRB1-03:02, HLA-DRB1-04:01, HLA-DQA1-03:01, HLA-DQA1-05:01, HLA-DQB1-02:01, HLA-DQB1-03:01, HLA-DQB1-03:02. HLA-DRB1-03:01-DQA1-05:01-DQB1-02:01, HLA-DRB1-04:01-DQA1-03:01-DQB1-03:01, HLA-DRB1-04:01-DQA1-03:01-DQB1-03:02, CTLA4 (c.+6230GA, rs3087243), CTLA4 (c.49AG, rs231775), PTPN22 (c.+1858 CT, rs2476601), PTPN22 (rs2476601), IL2Ra (c.AG rs10795791),VDR, Bsm I rs1544410; Apa I rs7975232, Taq I rs731236, tumor necrosis factor (TNF, c.-863GA, rs1800630), C-type lectin domain containing 16 (CLEC16A) (rs12708716), erb-B2 receptor tyrosine kinase 3 (ERBB3) gene (rs2292399), the interferon induced with helicase C domain 1 (IFIH1) gene (rs1990760), CTLA4, PTPN22, IL2RA, CLEA16A, ERBB3, CCR5, CD247, VDR, NAA25, STAT4, INS, CAPSL, CD226 and IFIH1 | |
Lupus | TPN22 (rs2476601) | Criswell et al. [39] |
Graves’ disease | CTLA-4, PTPN22, HLA-DR3, TSHR, TG, HLA-DR\(\beta\)1, FOXP3, CD40, IL2RA | |
Pernicious anemia | HLA-B8, DR3, DR5 | Zulfiqar and Andres [42] |
Sjogren’s syndrome | HLA-DR3 (DRB1:03:01) | Manuel et al. [43] |
Celiac disease | HLA-DQ2 and HLA-DQ8 haplotypes, CTLA-4, CCR5 | |
Hashimoto’s thyroids | CD25, CD40, FOXP3, CTLA4, PTPN22, thyroid stimulating hormone receptor, thyroglobulin, HLA-DR3, DRB1*04-DQB1*0301, HLA-DR B1-Arg74, CTLA4 gene +49A/G and CT 60, FoxP3, FoxP’s 2383CC polimorfizm, FOXE1, VAV3, CAPZB, PDE8B, TRIP2, LPP, FAM76B, RNASET2, CCR5, BACH2, ZFAT, SLC26A4, SESN3, DR5, DQ7 (HLA DQB1*0301, HLA DQB1*0304), DQw7, DRB1*04, DRB4*0101, HLA-A2, DRw53, VDR, TGF-beta, IFN-gamma, CYP27B1, IP6K3 | Mikosch et al. [44], Frommer and Kahaly [37], Zaletel and Gaberscek [46], Kherrour et al. [47] |